Strengthening inferential studies in the FDA Sentinel initiative: results from a methodological demonstration project
Year: 2025
Type: article
Language: en
Topic: Diabetes Treatment and Management
Authors and affiliations:
raw_author_name: Rishi J. Desai
raw_affiliation_strings: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. rdesai@bwh.harvard.edu
raw_author_name: Janick Weberpals
raw_affiliation_strings: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Haritha Pillai
raw_affiliation_strings: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Adebola Ajao
raw_affiliation_strings: Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA
raw_author_name: Mukund Desibhatla
raw_affiliation_strings: Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA
raw_author_name: Rebecca Hawrusik
raw_affiliation_strings: Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA
raw_author_name: José J. Hernández-Muñoz
raw_affiliation_strings: Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA
raw_author_name: Chanelle Jones
raw_affiliation_strings: Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA
raw_author_name: Jamal T. Jones
raw_affiliation_strings: Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA
raw_author_name: Joyce Lii
raw_affiliation_strings: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Jie Li
raw_affiliation_strings: Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA
raw_author_name: Jennifer G. Lyons
raw_affiliation_strings: Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA
raw_author_name: Ryan Schoeplein
raw_affiliation_strings: Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA
raw_author_name: Fatma M. Shebl
raw_affiliation_strings: Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA
raw_author_name: Sengwee Toh
raw_affiliation_strings: Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA
raw_author_name: Elisabetta Patorno
raw_affiliation_strings: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
raw_author_name: Sebastian Schneeweiss
raw_affiliation_strings: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA